Edition:
India

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

44.71USD
8:18pm IST
Change (% chg)

$0.59 (+1.34%)
Prev Close
$44.12
Open
$44.10
Day's High
$44.76
Day's Low
$44.05
Volume
9,938
Avg. Vol
90,255
52-wk High
$59.29
52-wk Low
$29.60

CBM.N

Chart for CBM.N

About

Cambrex Corporation (Cambrex) is a life sciences company. The Company provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services across the world to generic pharmaceutical companies. Cambrex operates through three segments, which are... (more)

Overall

Beta: 1.43
Market Cap(Mil.): $1,418.34
Shares Outstanding(Mil.): 32.15
Dividend: --
Yield (%): --

Financials

  CBM.N Industry Sector
P/E (TTM): 22.28 36.80 36.60
EPS (TTM): 1.98 -- --
ROI: 15.12 14.49 13.96
ROE: 20.79 15.33 14.92

BRIEF-Cambrex Q2 gaap earnings per share $0.63 from continuing operations

* Fy2016 earnings per share view $2.56, revenue view $475.4 million -- Thomson Reuters I/B/E/S

28 Jul 2016

BRIEF-Cambrex completes $50 mln investment in Iowa

* Cambrex completes $50 million investment in large scale API manufacturing and storage at its Charles City, Iowa Site Source text for Eikon: Further company coverage:

12 Jul 2016

BRIEF-Cambrex Corp says Co, subsidiary borrowers and guarantors entered into a credit agreement

* On may 18, 2016, cambrex corp, subsidiary borrowers party thereto and subsidiary guarantors party thereto entered into a credit agreement

23 May 2016

BRIEF-Cambrex Corp reports first quarter 2016 financial results

* Q1 adjusted earnings per share $0.50 from continuing operations

29 Apr 2016

Earnings vs. Estimates